Fundraising Fox
Portal Biotech
Founded 2021 · 70 employees on LinkedIn · 2 known investors
Find your way into Portal Biotech
Sign up to see every warm intro you have to Portal Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Portal Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Portal Biotech develops bench-top instruments that use nanopore biosensors coupled with machine learning to detect, sequence, and characterise single protein and metabolite molecules, revealing modifications, mutations, and isoforms. The technology, spun out of the Maglia Lab at the University of Groningen, serves academic research, biopharmaceutical, biotechnology, and industrial labs for proteomic and metabolomic analysis.
Investors · 2
How we know: Pillar VC's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$35M disclosed across 1 of 2 rounds · 2025
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Portal Biotech do?
- Portal Biotech develops bench-top instruments that use nanopore biosensors coupled with machine learning to detect, sequence, and characterise single protein and metabolite molecules, revealing modifications, mutations, and isoforms. The technology, spun out of the Maglia Lab at the University of Groningen, serves academic research, biopharmaceutical, biotechnology, and industrial labs for proteomic and metabolomic analysis.
- Who are Portal Biotech's investors?
- Portal Biotech's investors include Pillar VC, Earlybird Venture Capital.
- How much funding has Portal Biotech raised?
- Portal Biotech has disclosed $35M raised across 1 of its 2 known rounds.